173 related articles for article (PubMed ID: 34322788)
1. LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.
Chen H; Wei L; Luo M; Wang X; Zhu C; Huang H; Liu X; Lu H; Zhong Y
Cell Biol Toxicol; 2022 Dec; 38(6):995-1011. PubMed ID: 34322788
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
Zhang W; Zhang Y; Xi S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
4. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
Huang P; Li M; Tang Q; Jiang K; Luo Y
Apoptosis; 2022 Oct; 27(9-10):751-761. PubMed ID: 35759163
[TBL] [Abstract][Full Text] [Related]
5. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
6. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
Cheng JZ; Chen JJ; Wang ZG; Yu D
Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MINCR regulates irradiation resistance in nasopharyngeal carcinoma cells via the microRNA-223/ZEB1 axis.
Zhong Q; Chen Y; Chen Z
Cell Cycle; 2020 Jan; 19(1):53-66. PubMed ID: 31760895
[TBL] [Abstract][Full Text] [Related]
9. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
Hu W; Wang Y; Zhang Q; Luo Q; Huang N; Chen R; Tang X; Li X; Luo H
Cell Signal; 2023 Oct; 110():110833. PubMed ID: 37543098
[TBL] [Abstract][Full Text] [Related]
11. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
Feng B; Chen K; Zhang W; Zheng Q; He Y
J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
[TBL] [Abstract][Full Text] [Related]
12. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
Zhang W; Zhang Q; Cui Q; Xu Y
Hum Exp Toxicol; 2023; 42():9603271221150248. PubMed ID: 36607163
[TBL] [Abstract][Full Text] [Related]
13. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
Wang X; Jin Q; Wang X; Chen W; Cai Z
Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG7 promotes the proliferation of nasopharyngeal carcinoma by miR-514a-5p/ELAVL1 axis.
Hu W; Li H; Wang S
BMC Cancer; 2020 May; 20(1):376. PubMed ID: 32370736
[TBL] [Abstract][Full Text] [Related]
15. Regulatory Mechanism of lncRNA CTBP1-AS2 in Nasopharyngeal Carcinoma Cell Proliferation and Apoptosis via the miR-140-5p/BMP2 Axis.
Huang B; Li Y; Deng Z; Lan G; Si Y; Zhou Q
Protein Pept Lett; 2022; 29(7):621-630. PubMed ID: 35894463
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells.
Chen H; Luo M; Wang X; Liang T; Huang C; Huang C; Wei L
Cell Mol Biol Lett; 2021 Mar; 26(1):9. PubMed ID: 33726680
[TBL] [Abstract][Full Text] [Related]
17. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H
Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860
[TBL] [Abstract][Full Text] [Related]
18.
Ren D; Lu J; Han X; Xiong W; Jiang H; Wei Y; Wang Y
Biochem Cell Biol; 2021 Dec; 99(6):750-758. PubMed ID: 34767742
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
20. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
Xiong W; Li D; Ao F; Tu Z; Xiong J
Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]